1 / 29

Mrs AG

jaden
Download Presentation

Mrs AG

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

    1. Mrs AG

    3. History of presenting complaint Previous cancer of the breast Had mastectomy and radiotherapy Apr 2006 Diagnosed with bony metastatic disease Summer 2007

    4. History of presenting complaint Commenced on sodium clodronate 1.6grams/day in August 2007 Stopped after 2 days due to diarrhoea Restarted 3rd Sept 2007 at 400mg/day Stopped on the 14th Sept due to diarrhoea

    5. History of presenting complaint Then developed Nausea Poor appetite Uncontrollable shaking Paraesthesiae in hands and legs Muscle cramps Unable to mobilise

    6. Past medical history Metastatic Ca. breast Hypertension Hypercholesterolaemia

    7. Drug history Allergies Penicillin and Erythromycin Aspirin 75mg OD Atorvastatin 10mg ON Lisinopril 20mg OD Allopurinol 100mg OD Anastrazole 1mg OD Frusemide 40mg OD Esomeprazole 20mg OD

    8. Social and Family History Lives with husband Independent in all ADL’s normally Non-smoker, moderate alcohol No family history of note

    9. On examination Tremulous Tachycardic BP 160/86 Afebrile RR 20, Sats 97% on air

    10. On examination Clear chest Abdo soft and non-tender Marked resting and action tremor Peripheral paraesthesiae No signs of DVT

    11. Investigations ECG – Sinus tachycardia, normal QT CXR – Some areas of shadowing right and left lung fields ??mets Previous CT abdo/pelvis – widespread sclerotic bony lesions, ?lung mets

    12. Investigations Bloods on admission WCC 8.5, Hb 12.8 Na 145, K 3.8, Urea 5.5, Creat 71 Corr Ca 2+ 1.36, PO 4 1.60 LFT’s normal except Alk phos 166 TSH and haematinics normal

    13. Impression Profound hypocalcaemia secondary to bisphosphonate therapy and frusemide

    14. Treatment Commenced on Calcichew D3 Forte 2 tabs OD Given 10mls of 10% calcium gluconate Further 100mls of 10% calcium gluconate * 2 Magnesium 5 grams infused (Mg level 0.15 prior to infusion) Frusemide stopped

    15. Further tests Short synacthen test – normal response PTH 5.5 (1.6 – 6.9) PTH appears low for degree of hypocalcaemia, this may be due to hypomagnesaemia which can interfere with physiological release of PTH in hypocalcaemia

    16. Further tests Vitamin D level 15.3 <10 – deficiency 10-20 – may indicate deficiency >20 - adequate

    17. Patient progress 24/9/07 Feeling much better. No longer shaking as much, no paraesthesia, no cramps Mobile with zimmer frame Ca 2+ 2.11, Mg 0.53 25/9/07 Mobile independently on ward – discharged home

    18. Hypocalcaemia Hypocalcaemia occurs when calcium is lost from the extra cellular fluid in greater quantities than can be replaced by the intestine or bone.

    19. Symptoms/signs of hypocalcaemia Paraesthesiae of distal extremities and circumoral area Chvostek and Trousseau signs Muscle cramps Laryngospasm Tetany Seizures Prolonged QT interval which can progress to VF or heart block

    20. Causes of hypocalcaemia Vitamin D deficiency Hypomagnesaemia Loop diuretics Hypoparathyroidism Pseudohypoparathyroidism Chronic renal failure Post parathyroidectomy Rhabdomyolysis Malignant disease Acute pancreatitis Septic shock

    21. Causes of hypocalcaemia Hypoparathyroidism Deficiency of PTH leads to increased renal calcium excretion and decreased intestinal calcium absorption (secondary to reduced 1,25(OH)2D3 production) (Note: PTH stimulates renal hydroxylation of 25(OH)D3 to 1,25(OH)2D3)

    22. Causes of hypocalcaemia Pseudohypoparathyroidism Rare hereditary disorder Affects target-cell response to PTH PTH is raised Patients can have shortened metacarpals and metatarsals along with short stature.

    23. Causes of hypocalcaemia Malignancy Prostate and breast can cause increased osteoblastic activity leading to increased bone formation and hypocalcaemia. Rapid cell destruction secondary to chemotherapy increases serum phosphorus. This complexes with serum calcium leading to hypocalcaemia.

    24. Causes of hypocalcaemia Rhabdomyolysis Release of cellular phosphorus, again binding to serum calcium causing hypocalcaemia.

    25. Causes of hypocalcaemia Renal failure Reduced phosphorus excretion with continued intestinal phosphorus absorption leads to hyperphosphataemia This leads to decreased conversion of 25(OH)D3 to 1,25(OH)2D3 This leads to decreased intestinal calcium absorption.

    26. Causes of hypocalcaemia Hypocalcaemia and hypomagnesaemia often co-exist Can be due to decreased absorption or poor dietary intake. Hypomagnesaemia impairs PTH secretion and can interfere with its peripheral action.

    27. Causes of hypocalcaemia Pancreatitis Release of pancreatic lipase causing degradation of retroperitoneal omental fat Binding of calcium in the peritoneum resulting in hypocalcaemia. Septic shock Unknown mechanism

    28. Discussion There are a number of reports of symptomatic hypocalcaemia following intravenous bisphosphonate therapy. However, this is uncommon with oral therapy. Usually, compensatory mechanisms, i.e. increase in PTH secretion act to correct calcium levels.

    29. Discussion Newer, more potent bisphosphonates may reduce the effects of PTH on bone resorption. Hypomagnesaemia can impair the compensatory increase in PTH secretion. Patients should have calcium and vitamin D status checked along with magnesium, phosphate and renal function levels prior to commencing potent bisphosphonate therapy.

More Related